Ender Karaca, Ramazan Buyukkaya, Davut Pehlivan, Wu-Lin Charng, Kursat O Yaykasli, Yavuz Bayram, Tomasz Gambin, Marjorie Withers, Mehmed M Atik, Ilknur Arslanoglu, Semih Bolu, Serkan Erdin, Ayla Buyukkaya, Emine Yaykasli, Shalini N Jhangiani, Donna M Muzny, Richard A Gibbs, James R Lupski
CONTEXT: Pituitary stalk interruption syndrome (PSIS) is a rare, congenital anomaly of the pituitary gland characterized by pituitary gland insufficiency, thin or discontinuous pituitary stalk, anterior pituitary hypoplasia, and ectopic positioning of the posterior pituitary gland (neurohypophysis). The clinical presentation of patients with PSIS varies from isolated growth hormone (GH) deficiency to combined pituitary insufficiency and accompanying extrapituitary findings. Mutations in HESX1, LHX4, OTX2, SOX3, and PROKR2 have been associated with PSIS in less than 5% of cases; thus, the underlying genetic etiology for the vast majority of cases remains to be determined...
January 2015: Journal of Clinical Endocrinology and Metabolism